Patents Assigned to Nitric Biotherapeutics, Inc.
  • Patent number: 8352024
    Abstract: An electrokinetic delivery system for personal use in self-administration of a medicament to a treatment site on an individual includes a device shaped to conform with the shape of a portion of an individual's finger from a tip thereof to a location past the first finger joint. A self-contained power source is carried by the device and a first electrode is carried by the device adjacent a distal end portion thereof and the tip of the individual's finger. The first electrode is in electrical contact with the power source. A second electrode is carried by the device for contact with the individual's finger. The second electrode is in electrical contact with the power source. Upon application of the first electrode over a treatment site with the medicament disposed between the first electrode and the treatment site and completion of an electrical circuit through the individual's body and said electrode, the device applies current for electrokinetically driving the medicament into the treatment site.
    Type: Grant
    Filed: March 13, 2006
    Date of Patent: January 8, 2013
    Assignee: Nitric Biotherapeutics, Inc.
    Inventors: Julian L. Henley, Kuo Wei Chang, Joseph Potter, Dennis I. Goldberg, James Derouin
  • Patent number: 8328788
    Abstract: A method for delivering a substance to an infected nail of an individual is described. The method includes the step of applying a device to at least one infected nail of an individual, where the device includes at least one active electrode and at least one counter electrode, where the at least one counter electrode is in contact with the individual, and where the device is connected to at least one power source. The method also includes the steps of disposing a medicament between the at least one active electrode and the at least one infected nail, applying a salt solution to the at least one infected nail, and providing an electrical current from the power source to the at least one active electrode to facilitate delivery of the medicament into the region of the at least one infected nail.
    Type: Grant
    Filed: May 11, 2011
    Date of Patent: December 11, 2012
    Assignee: Nitric Biotherapeutics, Inc.
    Inventors: Julian L. Henley, Kuo Wei Chang, Joseph Potter, Dennis I. Goldberg, James Derouin
  • Patent number: 8321008
    Abstract: A device for electrokinetic delivery of medicament to a treatment site includes a cartridge having an active electrode and a membrane overlying the active electrode and a medicament or a medicament and an electrically conductive carrier therefor, carried by the membrane in electrical contact with the electrode. The electrode opens through a surface of the cartridge remote from the membrane for connection with an electrical connector carried by the device. An locking element releasably couples the cartridge to the housing.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: November 27, 2012
    Assignee: Nitric Biotherapeutics, Inc.
    Inventors: John S. Petersen, Dennis I. Goldberg, James W. Kelland, Paul K. Rand, Anthony Patrick Charles Jones, Robert W. Etheredge
  • Publication number: 20080206364
    Abstract: The present invention relates to compositions and methods for treatment of a patient affected with an autoimmune disorder, and in an embodiment, a skin-related autoimmune disorder. The treatment involves the application of gaseous nitric oxide to an affected patient, and in an embodiment, to the skin of an affected patient.
    Type: Application
    Filed: October 12, 2007
    Publication date: August 28, 2008
    Applicant: Nitric Biotherapeutics, Inc.
    Inventors: Frank J. McCaney, Alex Stenzler, Chris Miller
  • Publication number: 20080160107
    Abstract: The present invention relates to compositions and methods for treatment of blood and blood products using gaseous nitric oxide. The treatment involves the contacting blood or a blood product with gaseous nitric oxide.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 3, 2008
    Applicants: Nitric Biotherapeutics, Inc., Cardinal Health 207, Inc.
    Inventors: Frank J. McCaney, Alex Stenzler, Chris Miller